1 Mehnert, W., Mäder, K., “Solid lipid nanoparticles pro-duction, characterization and applications”, Adv. Drug Deliv. Rev., 47, 165—196(2001). 2 Gasco, M.R., “Method for producing solid lipid micro-spheres having a marrow size distribution”, US Pat., 5250236 (1993). 3 Müller, R.H., Radtke, M., Wissing, S.A., “Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations”, Adv. Drug Deliv. Rev., 54(Suppl. 1), S131—S155(2002). 4 Hu, F.Q., Hong, Y., Yuan, H., “Preparation and charac-terization of solid lipid nanoparticles containing peptide”, Int. J. Pharm., 273, 29—35(2004). 5 Schwarz, C., Mehnert, W., Lucks, J.S., Müller, R.H., “Solid lipid nanoparticles (SLN) for controlled drug de-livery І. Production, characterisation and sterilization”, J. Control. Release, 30, 83—96(1994). 6 Lamprecht, A., Bouligand, Y., Benoit, J.P., “New lipid nanocapsules exhibit sustained release properties for amiodarone”, J. Control. Release, 84, 59—68(2002). 7 Venkateswarlu, V., Manjunath, K., “Preparation, char-acterization and in vitro release kinetics of clozapine solid lipid nanoparticles”, J. Control. Release, 95, 627—638(2004). 8 Mühlen, A.Z., Mühlen, E.Z., Niehus, H., Mehnert, W., “Atomic force microscopy studies of solid lipid nanopar-ticles”, Pharm. Res., 13(9), 1411—1416(1996). 9 Liu, J., Xiao, Y., Allen, C., “Polymer-drug compatibility: A guide to the development of delivery systems for the anticancer agent, ellipticine”, J. Pharm. Sci., 93(1), 132—143(2004). 10 Six, K., Verreck, G., Peeters, J., Brewster, M., Mooter, G.V.D., “Increased physical stability and improved dis-solution properties of itraconazole, a class Π drug, by solid dispersions that combine fast- and slow-dissolving polymers”, J. Pharm. Sci., 93 (1), 124—131(2004). 11 Domb, A.J., Baltimore, M., “Lipsopheres for controlled delivery of substances”, US Pat., 5188837 (1993). 12 Rowe, R.C., “Adhesion of film coatings to tablet sur-faces-A theoretical approach based on solubility pa-rameters”, Int. J. Pharm., 41, 219—222(1988). 13 Rowe, R.C., “Polar/nonpolar interactions in the granula-tion of organic substrates with polymer binding agents”, Int. J. Pharm., 56, 117—124(1989). 14 Greenhalgh, D.J., Williams, A.C., Timmins, P., York, P., “Solubility parameters as predictors of miscibility in solid dispersions”, J. Pharm. Sci., 88 (11), 1182—1190(1999). 15 Suzuki, H., Sunada, H., “Influence of water-soluble polymers on the dissolution of nifedipine solid disper-sions with combined carriers”, Chem. Pharm. Bull., 45, 1688—1693(1997). 16 Hansen, C.M., “The three dimensional solubility pa-rameter–key to paint component affinities. 1: solvent, plasticizers, polymers and resins”, J. Paint Technol., 39, 104—117(1967). 17 Kreveken, D.V., Properties of Polymers, Elsevier, Am-sterdam (1990). 18 Li, J.S., Sun, J., Zhang, D.L., “Estimating the solubility parameters of rubber ingredients basing on group con-tribution”, Rubber Eng., 42(7), 393—395(1995). (in Chinese) 19 Jenning, V., Gohla, S., “Comparison of wax and glyc-eride solid lipid nanoparticles”, Int. J. Pharm., 196, 219—222(2000). 20 Sato, K., “Crystallization behaviour of fats and lipids—A review”, Chem. Eng. Sci., 56, 2255—2265(2001). 21 Hagemann, J.W., Crystallization and Polymorphism of Fats and Fatty Acids, Marcel Dekker Inc., New York (1988). 22 Freitas, C., Müller, R.H., “Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase”, Eur. J. Pharm. Bio-pharm., 47, 125—132(1999). 23 Mühlen, A.Z., Schwarz, C., Mehnert, W., “Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism”, Eur. J. Pharm. Bio-pharm., 45, 149—155(1998). 24 Chapman, D., “The polymorphism of glycerides”, Chem. Rev., 62, 433―456(1962). 25 Freitas, C., Müller, R.H., “Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion af-ter addition of electrolyte”, J. Microencaps., 16(1), 59—71(1999). 26 Souto, E.B., Wissing, S.A., Barbosa, C.M., Müller, R.H., “Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery”, In-tern. J. Pharm., 278, 71—77(2004). 27 Yoshino, H., Kobayashi, M., Samejima, M., “The influ-ence of drugs on the physical stability of fatty supposito-ries”, Chem. Pharm. Bull., 30, 992—1001(1982).
|